Pharmacology
- FDA Approval Of Tudorza Pressair For Long-term Treatment Of COPD
-
Almirall, S.A. (ALM.MC) and Forest Laboratories, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved Tudorza(TM) Pressair(TM) (aclidinium bromide inhalation powder) for the long-term maintenance treatment of bronchospasm associate ...
Article - Anna Ohlden - Jul 24 2012 - 11:00am
- FDA Advisory Committee RecommendsOcriplasmin For Symptomatic Vitreomacular Adhesion (VMA)
-
ThromboGenics NV, a biopharmaceutical company focused on developing ophthalmic medicines, today announced that the US Food and Drug Administration (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has recommended that the FDA grant ocriplasmin ap ...
Article - Anna Ohlden - Jul 28 2012 - 5:00am
- An Economic Case For More Natural Medicine?
-
With the Supreme Court decision to uphold mandatory health insurance purchasing under the Affordable Care Act, it's going to get more expensive. But for thousands of years people were able to go into the woods and get health care for free, so all is n ...
Article - News Staff - Jul 30 2012 - 3:30pm
- Ayurvedic Medications And Lead Poisoning
-
Despite extensive regulations and preventative efforts, lead poisoning, which can damage the brain, kidneys, and nervous and reproductive systems, still occurs in the United States. Babies are also at risk. Fetal exposure to lead can adversely affect neu ...
Article - News Staff - Aug 24 2012 - 9:22am
- Anthracycline And Trastuzumab For Breast Cancer Linked To Heart Problems
-
Women who have breast cancer and are treated with two chemotherapy drugs, anthracycline and trastuzumab, may experience more cardiac problems like heart failure than shown in previous studies, according to a new Cancer Research Network study by Group Heal ...
Article - News Staff - Aug 30 2012 - 8:00pm
- Male Birth Control Pill May Soon Be Ready
-
Want to avoid a baby mama without getting surgery or enduring condoms that are too small? Men may soon have the same choice as women when it comes to birth control. A male contraceptive pill has been talked about for decades, but so far none has been succ ...
Article - News Staff - Sep 5 2012 - 11:21pm
- VAS203 Traumatic Brain Injury Drug Exceeds Expectations In Phase IIa Exploratory Clinical Trial
-
vasopharm GmbH, a pharmaceutical company dedicated to the discovery and development of novel therapeutics for the treatment of cerebro- and cardiovascular diseases, today announces that the explorative phase IIa NOSTRA trial in Traumatic Brain Injury Pati ...
Article - Anna Ohlden - Sep 17 2012 - 10:00pm
- Is Oxytocin Really Evil?
-
Is oxytocin really evil? No, oxytocin is not evil. But not all of its effects turn you into an angel of bliss. Science bloggers had a blast a few weeks ago, caviling at Paul Zak's Moral Molecule thesis, digging up an old study showing that soldiers d ...
Article - Susan Kuchinskas - Sep 22 2012 - 10:00am
- Creatine Helps Depressed Women, Says Study
-
The muscle-building dietary supplement creatine helps women battling depressions, according to a study from South Korea and the University of Utah. It reports that women with major depressive disorder (MDD) who augmented their daily antidepressant with 5 ...
Article - News Staff - Sep 25 2012 - 6:30am
- VEGF-B Drug Candidate May Be Diabetes Research Breakthrough
-
CSL Limited has developed a new drug candidate that is able to prevent the development of type 2 diabetes and reverse its progression in animal models of the disease. The drug candidate blocks signaling by protein Vascular Endothelial Growth Factor B (VEG ...
Article - News Staff - Sep 30 2012 - 5:30am